These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23486186)

  • 1. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
    Soung do Y; Gentile MA; Duong LT; Drissi H
    Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
    Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
    Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
    Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
    Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
    Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
    Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis.
    Hayami T; Zhuo Y; Wesolowski GA; Pickarski M; Duong LT
    Bone; 2012 Jun; 50(6):1250-9. PubMed ID: 22484689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.
    Panwar P; Xue L; Søe K; Srivastava K; Law S; Delaisse JM; Brömme D
    J Bone Miner Res; 2017 Dec; 32(12):2415-2430. PubMed ID: 28745432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model.
    Pennypacker BL; Gilberto D; Gatto NT; Samadfam R; Smith SY; Kimmel DB; Duong le T
    J Orthop Res; 2016 Jan; 34(1):72-80. PubMed ID: 26178170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.
    Cao Y; Mori S; Mashiba T; Westmore MS; Ma L; Sato M; Akiyama T; Shi L; Komatsubara S; Miyamoto K; Norimatsu H
    J Bone Miner Res; 2002 Dec; 17(12):2237-46. PubMed ID: 12469918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.
    Zhuo Y; Gauthier JY; Black WC; Percival MD; Duong LT
    Bone; 2014 Oct; 67():269-80. PubMed ID: 25038310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
    Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
    J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.
    Ren ZY; Machuca-Gayet I; Domenget C; Buchet R; Wu Y; Jurdic P; Mebarek S
    PLoS One; 2015; 10(7):e0132513. PubMed ID: 26168340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.
    Gerstenfeld LC; Sacks DJ; Pelis M; Mason ZD; Graves DT; Barrero M; Ominsky MS; Kostenuik PJ; Morgan EF; Einhorn TA
    J Bone Miner Res; 2009 Feb; 24(2):196-208. PubMed ID: 19016594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
    Mukherjee K; Chattopadhyay N
    Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of alendronate on fracture healing and bone remodeling of femoral shaft in ovariectomized rats.
    Fu LJ; Tang TT; Hao YQ; Dai KR
    Acta Pharmacol Sin; 2013 Mar; 34(3):387-92. PubMed ID: 23459092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1Alpha,25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora.
    Cao Y; Mori S; Mashiba T; Kaji Y; Manabe T; Iwata K; Miyamoto K; Komatsubara S; Yamamoto T
    Bone; 2007 Jan; 40(1):132-9. PubMed ID: 16962400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
    Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM;
    J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
    Kayal RA; Tsatsas D; Bauer MA; Allen B; Al-Sebaei MO; Kakar S; Leone CW; Morgan EF; Gerstenfeld LC; Einhorn TA; Graves DT
    J Bone Miner Res; 2007 Apr; 22(4):560-8. PubMed ID: 17243865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.
    Wang YH; Qiu Y; Han XD; Xiong J; Chen YX; Shi HF; Karaplis A
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):715-23. PubMed ID: 23937065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.